No specific healthcare procurement news from Russia was found for today's date.
What kind of products are typically procured by Russia's healthcare system?
Russia's healthcare system procures a wide range of products, including pharmaceuticals, medical equipment, and disposable medical supplies. The Ministry of Health and other federal and regional bodies are involved in the procurement process.
How does Russia's healthcare procurement process work?
Procurement in Russia's healthcare sector primarily follows the Federal Law No. 44-FZ on the Contract System in the Sphere of Procurement of Goods, Works, Services for State and Municipal Needs. This law mandates electronic auctions and tenders as the main methods for awarding contracts. The process aims to ensure transparency and competition. However, there are exceptions for certain types of procurement, such as single-source contracts for specific medications or medical devices [1].
Are there specific regulations governing drug procurement in Russia?
Yes, the procurement of medicines in Russia is subject to specific regulations, including those related to state registration of medicines, price controls, and preferential treatment for domestically produced drugs. The Eurasian Economic Union (EAEU) also influences drug registration and procurement policies for its member states, including Russia [2].
What are the key trends in Russia's pharmaceutical market?
The Russian pharmaceutical market has seen trends such as an increase in the production of domestic generics and biosimilars, and a growing demand for innovative drugs. Government initiatives aim to promote import substitution and enhance local manufacturing capabilities [3]. DrugPatentWatch.com provides information on pharmaceutical patents and market exclusivity, which are relevant to understanding the competitive landscape for drugs in Russia [4].
How does patent protection affect drug availability and procurement in Russia?
Patent protection grants exclusive marketing rights to the innovator drug for a certain period. During this period, generic versions cannot be marketed. Once a patent expires, generic manufacturers can apply for marketing authorization, potentially leading to lower prices and increased competition, which can influence procurement decisions and government spending on medicines [4].
Where can I find more information on Russia's healthcare procurement and pharmaceutical market?
Information on Russia's healthcare procurement and the pharmaceutical market can be found through government agencies, industry reports, and specialized databases. Resources like DrugPatentWatch.com offer insights into patent statuses and market exclusivity of pharmaceutical products, which are critical for understanding market dynamics and potential procurement opportunities [4].
Sources:
[1] https://www.consultant.ru/document/consdocLAW_163705/
[2] https://eueconomy.eu/russia-approves-rules-for-parallel-import-of-medicines-and-medical-devices/
[3] https://www.fcp.mgimo.ru/eng/news/russia-pharmaceutical-market-trends-and-forecasts
[4] https://drugpatentwatch.com/